Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Solu-Medrol Infusion (methylprednisolone) Treatment Report
What is Solu-Medrol Infusion?

Solu-MedrolĀ® is a brand name for methylprednisolone sodium succinate for IV or IM admininstration. It is used as an anti-inflammatory or immunosuppressant agent for diseases of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin; also for graft-versus-host disease.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my MS progress 110 17
Other 77 13
Stiffness/Spasticity 23 4
Pain 21 4
Sensation 19 3
Vision 19 9

See all 132 patients currently taking Solu-Medrol Infusion


Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
13 21%
Moderate
27 44%
Mild
18 29%
None
4 6%

Most commonly reported side effects

Taste changed
33 53%
Sleeplessness
28 45%
Metallic taste in mouth
24 39%
Weight gain
21 34%
jumpy feeling
19 31%
flushed face
16 26%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Solu-Medrol Infusion. See all 46 dosages

  1000 as needed 1000mg as needed 1 g as needed 1g as needed 1g monthly 250mg as needed 2g as needed 3g as needed 500mg as needed 8 500mg as needed as needed daily mg as needed monthly 3 g yearly 1 g monthly 1 g every other week 1 mg every other week 3 g monthly 1 g weekly 1 daily 1 g daily 1 g one time 1 hr one time 40 mg monthly 60 mg monthly 3 g daily 3 g one time 4 g daily 125 mg monthly 5 g one time 5 other daily 10 g daily 16 mg daily 500 mg monthly 1000 mg monthly 1500 mg monthly 1000 mg every other week 500 mg weekly 1000 mg weekly 250 mg daily 250 mg one time 500 mg daily 1000 g daily 1000 mg daily 2000 mg daily
  3 Number of Patients: 3 6 Number of Patients: 6 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 12 Number of Patients: 12 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 13 Number of Patients: 13 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Solu-Medrol Infusion (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
202 85% Course of treatment ended: 85%
Doctor's advice
19 8% Doctor's advice: 8%
Did not seem to work
16 7% Did not seem to work: 7%
Side effects too severe
12 5% Side effects too severe: 5%
Other
12 5% Other: 5%
Not indicated
11 5% Not indicated: 5%

See all 237 patients who’ve stopped taking Solu-Medrol Infusion

Currently Taking Solu-Medrol Infusion

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
5
3
8
17
14
18

Stopped Taking Solu-Medrol Infusion

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
149
13
9
13
13
40

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
57 92%
Usually
3 5%
Sometimes
0 0%
Never
2 3%

Burden

Difficulty being on treatment

Very
6 10%
Somewhat
13 21%
A little
23 37%
Not at all
20 32%

Cost

Paid out of pocket

$200+
3 5%
$100-199
2 3%
$50-99
4 6%
$25-49
0 0%
< $25
19 31%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.